Epoetin Alfa
Brand name: Epogen
Rank #248 of 500 drugs by total cost
$51.4M
Total Cost
34,952
Total Claims
$51.4M
Total Cost
1,126
Prescribers
$1,470
Cost per Claim
4,511
Beneficiaries
36,841
30-Day Fills
$46K
Avg Cost/Provider
31
Avg Claims/Provider
About Epoetin Alfa
Epoetin Alfa (sold as Epogen) was prescribed 34,952 times by 1,126 Medicare Part D providers in 2023, costing the program $51.4M. At $1,470 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 245 | Pegloticase (Krystexxa) | $52.2M | 1,134 |
| 246 | Estrogens, Conjugated (Premarin) | $52.0M | 130,171 |
| 247 | Ranolazine (Ranolazine Er) | $51.6M | 381,631 |
| 248 | Epoetin Alfa (Epogen) | $51.4M | 34,952 |
| 249 | Nifedipine (Nifedipine Er) | $51.2M | 1,249,866 |
| 250 | Clobetasol Propionate (Clobetasol Propionate) | $51.2M | 758,575 |
| 251 | Sodium,calcium,mag,pot Oxybate (Xywav) | $51.1M | 3,234 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology